Comparing blood thinners after ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares four different blood-thinning medicines (indobufen, aspirin, cilostazol, and clopidogrel) to see how well they prevent another stroke in people who recently had an ischemic stroke. It may help doctors choose the best option for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain).
- You were treated at Nanfang Hospital between January 2020 and December 2025.
- You started one of the study medicines within 7 days after leaving the hospital.
- You have follow-up records at 1 year after starting treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This study tests whether giving the blood-thinning drug tirofiban for a shorter or longer time after standard clot-busting treatment improves recovery from a stroke. It aims to find the best duration to prevent further damage while avoiding side effects.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
This study compares two ways to treat a minor stroke: taking two blood-thinning pills (aspirin and clopidogrel) versus receiving a clot-busting medicine (alteplase) through an IV. The goal is to see which approach works better and has fewer side effects.
This study tests whether adjusting blood-thinner medication based on a blood test can better prevent another stroke in people who recently had a minor stroke or a high-risk mini-stroke. It aims to find the safest and most effective dose for each patient.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.